Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease

Código QR

Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease

The significance of sclerostin for bone and cardiovascular health in patients with chronic kidney disease (CKD) is complex and incompletely understood. Experimental evidence suggests that anti-sclerostin therapy shows diminished efficacy on bone in the setting of CKD. Limited clinical evidence sugge...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Daniel Cejka
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	sclerostin romosozumab chronic kidney disease (CKD) chronic kidney disease–mineral and bone disorder (CKD–MBD) cardiovascular safety Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/9bdc449e9205454ab300977f5151fe08
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

High Unawareness of Chronic Kidney Disease in Germany
por: Susanne Stolpe, et al.
Publicado: (2021)

PATTERNS OF CHRONIC KIDNEY DISEASE – MINERAL BONE DISEASE AND ITS RELATIONSHIP WITH SOCIO-DEMOGRAPHIC FACTORS AMONG THE PATIENTS OF CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS
por: Batool Butt, et al.
Publicado: (2021)

CKD Stages, Bone Metabolism Markers, and Cortical Porosity Index: Associations and Mediation Effects Analysis
por: Yan Xiong, et al.
Publicado: (2021)

Plant-Based versus Animal-Based Low Protein Diets in the Management of Chronic Kidney Disease
por: Carmen-Antonia Mocanu, et al.
Publicado: (2021)

Urinary Beta-2-Microglobulin and Late Nephrotoxicity in Childhood Cancer Survivors
por: Eryk Latoch, et al.
Publicado: (2021)

Serum sirtuin 1 is independently associated with intact PTH among patients with chronic kidney disease
por: Bielach-Bazyluk A, et al.
Publicado: (2021)

Relation of Baseline Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Contrast-Induced Nephropathy following Percutaneous Coronary Intervention among Chronic Kidney Disease Patients
por: Lior Lupu, et al.
Publicado: (2021)

Should clinical laboratories adapt to the reality of chronic kidney disease in the determination of parathyroid hormone?
por: González-Casaus María Luisa, et al.
Publicado: (2021)

The ensemble learning model is not better than the Asian modified CKD-EPI equation for glomerular filtration rate estimation in Chinese CKD patients in the external validation study
por: Li Zhao, et al.
Publicado: (2021)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen JW, et al.
Publicado: (2018)

Effectiveness of CKD Exacerbation Countermeasures in Izumo City
por: Takafumi Ito, et al.
Publicado: (2021)

Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China
por: Wang X, et al.
Publicado: (2020)

Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study
por: Nishikawa A, et al.
Publicado: (2016)

Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study
por: Patricia Muñoz Ramos, et al.
Publicado: (2021)

The Glomerular Filtration Rate: From the Diagnosis of Kidney Function to a Public Health Tool
por: Ana Maria Cusumano, et al.
Publicado: (2021)

The impact of metformin in chronic kidney disease-mineral and bone disorder
por: Rohollah Masumi, et al.
Publicado: (2021)

Compromised calcium and phosphorus metabolism in patients with diabetes mellitus and chronic kidney disease
por: Margarita Stanislavovna Biragova, et al.
Publicado: (2012)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Yousuf Waheed, et al.
Publicado: (2021)

Serum fatty acid binding protein 4 levels are associated with abdominal aortic calcification in peritoneal dialysis patients
por: Sijia Zhou, et al.
Publicado: (2021)

Nephrotoxicity after radionuclide therapies
por: Ashwin Singh Parihar, et al.
Publicado: (2022)

Chronic Intractable Pruritus in Chronic Kidney Disease Patients: Prevalence, Impact, and Management Challenges — A Narrative Review
por: Świerczyńska K, et al.
Publicado: (2021)

Bone Marrow Hypocellularity in Patients with End-Stage Kidney Disease
por: Chia-Chen Hsieh, et al.
Publicado: (2021)

Spectrally and Time-Resolved Fluorescence Imaging of 22-NBD-Cholesterol in Human Peripheral Blood Mononuclear Cells in Chronic Kidney Disease Patients
por: Ingrid Lajdova, et al.
Publicado: (2021)

Chronic Kidney Disease Related Anemia- A Narrative Review
por: Martina Hrvačić, et al.
Publicado: (2021)

Association between metabolic parameters and risks of anemia and electrolyte disturbances among stages 3–5 chronic kidney disease patients in Taiwan
por: Adi Lukas Kurniawan, et al.
Publicado: (2021)

Calcium and phosphorus parameters and their association with serum parathormone in chronic kidney patients on hemodialysis
por: Mendes,Vitória Ribeiro, et al.
Publicado: (2021)

The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer
por: Arkadiusz Zygmunt, et al.
Publicado: (2021)

Comparison of [18F] NaF PET/CT dynamic analysis methods and a static analysis method including derivation of a semi-population input function for site-specific measurements of bone formation in a population with chronic kidney disease-mineral and bone disorder
por: M. H. Vrist, et al.
Publicado: (2021)

Cholemic Nephropathy as Cause of Acute and Chronic Kidney Disease. Update on an Under-Diagnosed Disease
por: Francesca Tinti, et al.
Publicado: (2021)

Longitudinal Follow-Up and Outcomes for Chinese Patients with Stage 1–4 Chronic Kidney Disease
por: Jinwei Wang, et al.
Publicado: (2021)

Risk of kidney health among returnee Nepali migrant workers: A survey of nephrologists
por: Nirmal Aryal, et al.
Publicado: (2021)

A neural network for glomerulus classification based on histological images of kidney biopsy
por: Giacomo Donato Cascarano, et al.
Publicado: (2021)

Pneumonia in Patients with Chronic Kidney Disease Admitted to Nephrology Department of a Tertiary Care Center: A Descriptive Cross-sectional Study
por: Abhishek Pant, et al.
Publicado: (2021)

Recovery Of Bone And Muscle Mass In Patients With Chronic Kidney Disease And Iron Overload On Hemodialysis And Taking Combined Supplementation With Curcumin And Resveratrol
por: Murillo Ortiz BO, et al.
Publicado: (2019)

Cardiovascular Pathophysiology in Chronic Kidney Disease: Opportunities to Transition from Disease to Health
por: Matthew I. Tomey, et al.
Publicado: (2014)

Editorial: Nutritional Aspects of Kidney Disease
por: Alice Sabatino, et al.
Publicado: (2021)

Cardiorenal syndrome in patients with chronic kidney disease and diabetes mellitus
por: Irina Mikhailovna Kutyrina, et al.
Publicado: (2013)

Exploring sleep disorders in patients with chronic kidney disease
por: Nigam G, et al.
Publicado: (2018)

Chronic Kidney Disease and Arterial Stiffness: A Two-Way Path
por: Felipe Inserra, et al.
Publicado: (2021)

Evaluation of adductor pollicis muscle thickness obtained by ultrasonography and adipometer in patients with chronic kidney disease under conservative treatment
por: Pereira,Priscila, et al.
Publicado: (2020)